Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a new revision label (v3.3.2) and removes the previous label (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1. No visible content or functionality changes observed on the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedRemoved the notice about a lapse in government funding and related operating status information from the page.SummaryDifference0.3%

- Check46 days agoChange DetectedResults section and study outcomes have been added, including measures such as progression-free survival and objective response rate, along with safety data. The study record dates were updated to reflect results posting and completion status.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded: Revision: v3.2.0. Removed: Ovarian cancer. Overall, the page now reflects a newer version tag and omits a previously mentioned health topic.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdated version to v3.1.0 and removed the term “Ovarian cancer.”SummaryDifference0.1%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.